Benjamin F. Edwards & Company’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Benjamin F. Edwards & Company's EXAS Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its Exact Sciences (EXAS) stake by 94% in Q2 2024, selling an estimated $23.5K and leaving 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.
Benjamin F. Edwards & Company first reported a position in EXAS in Q2 2015 and has held it in 23 quarters since. The position peaked at $31K in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.
- Benjamin F. Edwards & Company held 25 shares of Exact Sciences worth $1K as of Q2 2024.
- Benjamin F. Edwards & Company sold 427 Exact Sciences shares in Q2 2024, an estimated $23.5K.
- Exact Sciences made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2090 holding.
- Benjamin F. Edwards & Company first reported a position in Exact Sciences in Q2 2015 and has held it in 23 quarters since.
- Benjamin F. Edwards & Company's Exact Sciences position peaked at $31K in Q1 2024.
- 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.